VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS

VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S.
Yahoo Finance

Vectorized Antibodies Market Research Report 2025-2034 | Revolutionizing Chronic Disease Treatment with In-Vivo Therapeutic Production

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Vectorized Antibodies Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...
FierceBiotech

AbbVie, Voyager add Parkinson’s disease, $65M to ‘vectorized’ antibody pact

A year after AbbVie and Voyager Therapeutics teamed up on Alzheimer’s disease, they are expanding their partnership to include Parkinson’s disease and other diseases in which misfolded alpha-synuclein ...
SiliconANGLE

Data streaming startup Vectorized raises $15.5M to take on Apache Kafka

Vectorized Inc., a new data management startup, today disclosed that it has raised $15.5 million across two funding rounds from Lightspeed Venture Partners and Alphabet Inc.’s GV fund. The startup’s ...
Business Wire

Encoded Demonstrates Therapeutic Potential of a Vectorized miRNA-based Approach for Angelman Syndrome at the FAST Annual Global Science Summit

ORLANDO, Fla.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, announced today that ...
ascopubs.org

Vectorized gene therapy of liver tumors: Safety and proof of concept of TG4023 (MVA-FCU1)/5-FC combination.

A randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. This is an ASCO Meeting Abstract from the 2012 ASCO ...